Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poly(glutamic acid) for biomedical applications.

A Richard1, A Margaritis

  • 1Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, Canada.

Critical Reviews in Biotechnology
|January 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automatic analysis of negation cues and scopes for medical texts in French using language models.

Computers in biology and medicine·2025
Same author

Correction: Perforated peptic ulcer disease in transferred patients is associated with significant increase in length of stay.

Surgical endoscopy·2024
Same author

Perforated peptic ulcer disease in transferred patients is associated with significant increase in length of stay.

Surgical endoscopy·2024
Same author

A longitudinal comparison of emotional, behavioral and attention problems in autistic and typically developing children.

Psychological medicine·2023
Same author

REALMS: Resilient exploration and lunar mapping system.

Frontiers in robotics and AI·2023
Same author

Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.

Journal of virology·2020
Same journal

Sustainable and green novel sorbent-based immobilization of PFAS and their enhanced adsorption to treat environmental contamination.

Critical reviews in biotechnology·2026
Same journal

Advances, challenges, and opportunities in engineering C5 and C6 sugar transporters in yeast for bio-based industrial biotechnology.

Critical reviews in biotechnology·2026
Same journal

Microbial engineering for the conversion of C1 feedstocks into value-added bioproducts: recent advances and perspectives.

Critical reviews in biotechnology·2026
Same journal

A step forward toward improved cold tolerance in rice: integrating physiological insights with cutting-edge genomic approaches.

Critical reviews in biotechnology·2026
Same journal

Emerging role of nanotechnology in the protection of BT biopesticide from UV radiations.

Critical reviews in biotechnology·2026
Same journal

Tuning molecular weight of poly-γ-glutamic acid: advanced biosynthetic engineering approaches and diversified applications.

Critical reviews in biotechnology·2026
See all related articles

Poly(glutamic acid) conjugates enhance anti-cancer drug delivery, improving effectiveness and reducing toxicity. Further optimization of this polymer is crucial for advancing drug delivery applications.

Area of Science:

  • Oncology
  • Polymer Chemistry
  • Drug Delivery

Background:

  • Paclitaxel is a key chemotherapeutic agent.
  • Poly(glutamic acid) conjugates show promise for improved cancer therapy.
  • Current research focuses on optimizing poly(glutamic acid) for drug delivery.

Purpose of the Study:

  • To evaluate the potential of poly(glutamic acid) as a drug delivery vehicle.
  • To assess the efficacy and toxicity of paclitaxel-poly(glutamic acid) conjugates.
  • To highlight the importance of optimizing poly(glutamic acid) for clinical viability.

Main Methods:

  • Preclinical studies involving paclitaxel-poly(glutamic acid) conjugates.
  • Comparative analysis of drug delivery to tumor sites versus non-tumor sites.

Related Experiment Videos

  • Investigation of poly(glutamic acid) conjugation with various cancer drug families.

    • Main Results:

    • Preclinical data indicate preferential delivery of paclitaxel to tumor sites with poly(glutamic acid) conjugation.
    • Conjugation with poly(glutamic acid) demonstrated improved effectiveness and reduced toxicity for other cancer drugs.
    • Clinical trials are ongoing for paclitaxel-poly(glutamic acid) conjugates.

    Conclusions:

    • Poly(glutamic acid) conjugation represents a promising strategy for enhancing cancer drug delivery.
    • This approach offers potential for improved therapeutic outcomes and reduced side effects.
    • Further optimization of poly(glutamic acid) is essential for the successful clinical translation of this technology.